Advertisement

The Latest

In this episode, Rory KJ Murphy, MD, neurosurgical, orthopedic, and minimally invasive spine surgeon at Barrow Neurological Institute, discusses evolving debates around multilevel cervical disc replacement versus fusion, emerging research in spinal cord injury care, and the growing role of…

In this episode, Catherine Chang, Chief Quality Officer at Prisma Health, joins the podcast to discuss expanding urgent care as a strategy to improve access, how ambient listening technologies are supporting clinicians, and the tools health systems can adopt to…

The Assistant Secretary for Technology Policy and the Office of the National Coordinator for Health Information Technology issued a request for information seeking public input on diagnostic imaging interoperability standards and certification. The request asks stakeholders to weigh in on…

Each year, poison control centers collectively save an estimated $3.1 billion for healthcare systems, a RAND study found. The 2026 report looked at the impact of that nation’s 53 poison centers. It found for every $1 spent on poison centers,…

Construction has begun on Baptist Health Sunrise (Fla.) Hospital, a 100-bed inpatient facility. Five things to know: 1. The planned seven-story, 340,000-square-foot facility is expected to open to patients in 2029 and will serve residents of Sunrise and western Broward…

Sanofi has discontinued development of its next-generation mRNA-based seasonal flu vaccine. According to its 2025 earnings documents, the drugmaker said it halted its phase 1 trial for an mRNA seasonal influenza vaccine and does not anticipate launching an mRNA-based seasonal…

The FDA has delayed approval of Aquestive Therapeutics’ new drug application seeking approval of Anaphylm, a sublingual epinephrine film for the treatment of Type 1 allergic reactions, including anaphylaxis. The agency issued a complete response letter Jan. 30, citing deficiencies…

Advertisement